LQDA · Medicine & biotech
Liquidia
Makes Yutrepia, an inhaled medicine for a rare lung disease.
What the manager says
In short: Lung-disease drug maker awaiting a key patent ruling against a rival.
The numbers
The fund’s letter names this company but doesn’t say how much of the fund is in it.
This fund doesn’t file the government report, so share counts aren’t public.